title: Response to the Letter: Comment to letter by Segar L.
authors: Diabetes, Endocrinology, and Obesity Branch; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
authors: Simeon
authors: S
authors: Taylor
mesh_terms: D016883:Diabetic Ketoacidosis / Q000139:chemically induced*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D007004:Hypoglycemic Agents; D000077203:Sodium-Glucose Transporter 2 Inhibitors